Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

NCT00215826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Acute Respiratory Syndrome

Interventions

DRUG: Alferon LDO

Sponsor

AIM ImmunoTech Inc.